EsA could reduce the release of platelet activating factor (PAF) from rat macrophages, and inhibit interleukin-1 and interleukin-6 production from routine macrophages. The reducing effects of EsA on the release of TNF, IL-1, IL-6 and PAF may explain its anti-inflammatory effect.
. Experiments have shown that it has strong anti-inflammatory effects. It is now known that tumour necrosis factor (TNF) possess a number of properties of inflammatory response. 2'3 Platelet activating factor (PAF), interleukin-1 and interleukin-6 are also inflammatory mediators. It has been shown that EsA inhibited the production of PAF by A23187 stimulated rat macrophages, 4 
